CTRI/2023/07/055593尚未招募2 期
AYURVEDIC MANAGEMENT OF NON-PROLIFERATIVE DIABETIC RETINOPATHY (MADHUMEHAJANYA TIMIRA) WITH PANCHATIKTA PANCHAPRASRUTIKA BASTI, SARIVADI ANJANA AND VASAKADI KWATHA â?? AN OPEN LABEL RANDOMISED CONTROLLED CLINICAL STUDY - NI
Government Akhandanand Ayurved College0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients willing for present treatment.
- •2. Age group between 18-70 years of either sex having diabetes mellitus.
- •3. Patients having moderate to good glycemic control (FBS < 220 mg/dl, PPBS < 300 mg/dl) with ongoing treatment
- •4. The patient with detectable ophthalmoscopic features of NPDR with or without visual disturbances
- •5. The patient presenting with signs and symptoms of NPDR with or without diabetic macular oedema [DME]
- •6. Patients of NPDR who have undergone modern medical management and Laser Photocoagulation therapy previously for the same but with persisting symptoms and/or signs are also included in the study.
排除标准
- •1. Age less than 18 years and more than 70 years
- •2. Proliferative diabetic retinopathy
- •3. Contraindicated for Anjana and Basti
- •4. DR associated with pregnancy
- •5. Any media opacity hampering ophthalmoscopic examination like iridocyclitis, corneal opacity, mature cataract, etc.
- •6. Vision hampering other diseases like, glaucoma, ARMD etc.
- •7. Chronic debilitating diseases like HIV, Carcinoma etc.
研究者
相似试验
进行中(未招募)
不适用
Religious leaders and diabetes prevention in BangladeshPrevention of diabetesNutritional, Metabolic, EndocrineISRCTN91564707Ministry of Health and Family Welfare824
已完成
2 期
A CLINICAL TRIAL TO FIND OUT THE TREATMENT OF DIABETIC POLYNEUROPATHY BY AN AYURVEDIC MEDICINECTRI/2011/07/001885iranjan Y60
进行中(未招募)
不适用
Optimised treatment for pre-existing diabetic macular oedema during cataract surgeryDiabetic Macular Oedema in type 2 diabetic patients with visually significant cataractEar, Nose and ThroatCataract, diabetic macular oedema, type 2 diabetes mellitus with ophthalmic complicationsISRCTN18293240Chinese University of Hong Kong92
已完成
不适用
Treatment of Clinically Significative diabetic Macular Edema: influence of Bevacizumab, Triamcinolone and the combination of both plus macular grid thermal laser Photocoagulation of subthresholdISRCTN10939948Opthalmological Foundation of the Mediterranean (Fundacion Oftalmologica del Mediterraneo) (Spain)60
招募中
不适用
Glycaemic control in patients with type 2 diabetes and colorectal- or breast cancer treated with curative intentType 2 diabetes (T2DM)Breast cancer/borstkankerColorectal cancer/colorectale kankerHypertension/hypertensieDyslipidemia/dyslipidemieNL-OMON23282Diabetes Kenniscentrum Zwolle156
